Publications and communications of Jonathan Bruyr

Galvan, B., Ongena, L., Bruyr, J., Fettweis, G., Lucarelli, E., Lavergne, A., Mariavelle, E., O'Grady, T. M., Hassoun, Z. E. O., Claes, M., Dubois, L., Lee, K. A. W., Kruys, V., Gueydan, C., Durand, J., Hervouet, E., Geyer, F. H., Banito, A., Imle, R., ... Dequiedt, F. (16 July 2025). Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma. Nature Communications, 16 (1), 6537. doi:10.1038/s41467-025-61725-x

Zuliani, B.* , Ongena, L.* , Claes, M., Bruyr, J., & Dequiedt, F.*. (29 January 2025). The role of m6A mRNA modification during endothelial-to-mesenchymal transition [Poster presentation]. Séminaire Télévie 2025.
* These authors have contributed equally to this work.

Lucarelli, E., Ongena, L., Dubois, L., Galvan, B., Bruyr, J., & Dequiedt, F. (17 October 2024). FET fusion oncoproteins rewire alternative splicing patterns to drive sarcomagenesis [Poster presentation]. EMBO/EMBL Symposium: The complex life of RNA, Heidelberg, Germany.

Zuliani, B.* , Ongena, L.* , Claes, M., Bruyr, J., & Dequiedt, F.*. (13 September 2024). The role of m6A mRNA modification during endothelial-to-mesenchymal transition [Poster presentation]. GIGA day 2024.
* These authors have contributed equally to this work.

Zuliani, B.* , Ongena, L.* , Claes, M., Bruyr, J., & Dequiedt, F. (14 July 2024). The role of m6A mRNA modification during endothelial-to-mesenchymal transition [Poster presentation]. 2024 Post-Transcriptional Gene Regulation GRC.
* These authors have contributed equally to this work.

Zuliani, B.* , Ongena, L.* , Claes, M., Bruyr, J., & Dequiedt, F. (30 May 2024). The role of m6A mRNA modification during endothelial-to-mesenchymal transition [Poster presentation]. The Interuniversity Ph.D. Student Day.
* These authors have contributed equally to this work.

Veloso, A.* , Bleuart, A.* , Conrard, L., Orban, T., Bruyr, J., Cabochette, P., Germano, R. F. V., Schevenels, G., Bernard, A., Zindy, E., Demeyer, S., Vanhollebeke, B., Dequiedt, F.* , & Martin, M.*. (27 February 2024). The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafish. BMC Biology, 22 (1), 51. doi:10.1186/s12915-024-01850-z
* These authors have contributed equally to this work.

Zuliani, B.* , Ongena, L.* , Claes, M., Bruyr, J., & Dequiedt, F.*. (06 February 2024). The role of m6A mRNA modification during endothelial-to-mesenchymal transition [Poster presentation]. Séminaire Télévie 2024.
* These authors have contributed equally to this work.

O'Grady, T.* , NJOCK, M.-S.* , Lion, M., Bruyr, J., Mariavelle, E., Galvan, B., Boeckx, A., Struman, I.* , & Dequiedt, F.*. (24 March 2022). Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels. BMC Biology, 20 (1), 72. doi:10.1186/s12915-022-01277-4
* These authors have contributed equally to this work.

Saulnier, O.* , Guedri, K.* , Aynaud, M.-M., Chakraborty, A., Bruyr, J., Pineau, J., O’Grady, T., Mirabeau, O., Grossetête, S., Galvan, B., Claes, M., Hassoun, Z. E. O. G., Sadacca, B., Laud, K., Zaïdi, S., Surdez, D., Baulande, S., Rambout, X., Tirode, F., ... Dequiedt, F.*. (2021). ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion. Nucleic Acids Research. doi:10.1093/nar/gkab305
* These authors have contributed equally to this work.

Bacquelaine Veloso, A., Dequiedt, F., Bruyr, J., & Orban, T. (2016). Study of Developmental and Molecular Processes Sorbs1 Regulated by using a combination of in vitro and in vivo models. PSI GIGA ULg. https://orbi.uliege.be/handle/2268/204006